Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04066790
What this trial is testing

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 12
Testing effectiveness (Phase 2)UnknownNCT03562390
What this trial is testing

Irinotecan for Advanced and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Liaoning Cancer Hospital & Institute 124
Early research (Phase 1)Ended earlyNCT03360006
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 30
Testing effectiveness (Phase 2)UnknownNCT03386552
What this trial is testing

Lidocaine Pertubation as a Treatment for Unexplained Infertility

Who this might be right for
Unexplained Infertility
Isifer AB 120
Testing effectiveness (Phase 2)Study completedNCT03154749
What this trial is testing

DCb (Docetaxel/Carboplatin) Versus EC-D (Epirubicin/Cyclophosphamide Followed by Docetaxe) as Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer
Guangdong Provincial People's Hospital 93
Testing effectiveness (Phase 2)Study completedNCT00405938
What this trial is testing

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
SCRI Development Innovations, LLC 79
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07367178
What this trial is testing

Study of Sacituzumab Govitecan With Atropine to Improve Tolerability in Advanced TNBC and HR+/HER2- Breast Cancer

Who this might be right for
Breast CancerAdvanced HR+/HER2- Breast CancerAdvanced Triple-Negative Breast Cancer
MedSIR 30
Testing effectiveness (Phase 2)Looking for participantsNCT06038578
What this trial is testing

TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGastric CancerGastroesophageal Junction Adenocarcinoma
Toray Industries, Inc 146
Testing effectiveness (Phase 2)Study completedNCT00014508
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00853125
What this trial is testing

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 10
Testing effectiveness (Phase 2)Study completedNCT02055976
What this trial is testing

Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects

Who this might be right for
Hypercholesterolemia
Pfizer 218
Testing effectiveness (Phase 2)Study completedNCT00475150
What this trial is testing

Cediranib Maleate in Treating Patients With Relapsed, Refractory, or Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+8 more
National Cancer Institute (NCI) 39
Testing effectiveness (Phase 2)Study completedNCT00466791
What this trial is testing

Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

Who this might be right for
Attention Deficit Disorder With Hyperactivity
Noven Therapeutics 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT06391710
What this trial is testing

HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Fujian Shengdi Pharmaceutical Co., Ltd. 203
Testing effectiveness (Phase 2)Ended earlyNCT00318110
What this trial is testing

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Center for International Blood and Marrow Transplant Research 4
Testing effectiveness (Phase 2)Study completedNCT04498910
What this trial is testing

LY3451838 in Participants With Migraine

Who this might be right for
Migraine
Eli Lilly and Company 38
Testing effectiveness (Phase 2)Looking for participantsNCT05241249
What this trial is testing

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
Susan E. Bates 37
Testing effectiveness (Phase 2)Looking for participantsNCT02598349
What this trial is testing

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Proton Collaborative Group 60
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Testing effectiveness (Phase 2)Looking for participantsNCT00501826
What this trial is testing

Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
T Acute Lymphoblastic LeukemiaT Lymphoblastic Lymphoma
M.D. Anderson Cancer Center 160
Next Page